HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

HHS Extends Covid-19 PHE Another 90 Days

January 12, 2023 by David Kopf

Secretary of Health and Human Services Xavier Becerra has extended the Covid-19 public health emergency for another 90 days until what would be a April 11 expiration date.

This means that U.S. healthcare and the HME industry, in specific, will continue operating under policy relaxations and different reimbursement guidelines. For the HME industry, that includes:

  • The 75/25 blended rate in non-rural/non-competitive bidding areas.
  • NCD/LCD flexibility allowing expanded use of home-based respiratory products/therapy, as well as infusion and anticoagulation devices.
  • Waiver of face-to-face requirements for many products, which allows the use of telehealth for items that are not included in the waiver, such as power mobility devices.
  • A 6.2 percent increase in Medicaid FMAP match (this will remain in effect through the end of the quarter in which the PHE expires).
  • State Medicaid waivers and flexibilities tied to the PHE (states can, however, end flexibilities they have granted at their discretion).
  • TRICARE reimbursement increases that are tied to the Medicare rate relief.

There was much discussion as to whether or not the last extension, made in October, would be the final extension for the PHE, given that much of the country has transitioned out of lockdown some time ago.

However, in a May 10, 2022 letter to U.S. governors, Becerra reaffirmed HHS’s commitment to providing at least 60 days advance notice before ending the PHE. Based on that information, HHS would have given that advanced notice in mid-November, and clearly it did not.

Now, industry stakeholders will watch for any kind of advance notice on Feb. 11, the 60-day point before April 12.

Related Articles Read More >

HME Business Survey: Call for Participants on Revenue Cycle & Operational Technology
Home medical equipment professionals are eligible to take the new survey.
Sumitomo Corp. Acquires ActivStyle LLC in Latest HME Investment
Last month, Sumitomo announced it had increased its stake in Vast Medical Holdings, parent company of HME provider Quest.
May 2025: How Science Is Backing HME
New research is demonstrating the clinical and financial value of home medical equipment.
ASPEN, WCCC Launch Industry Surveys
Featuring the American Society for Parenteral and Enteral Nutrition and the Wound Care Collaborative Community.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
continuum event
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe